GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Common Stock

Genflow Biosciences (STU:WQ5) Common Stock : €0.12 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Common Stock?

Genflow Biosciences's quarterly common stock declined from Jun. 2023 (€0.10 Mil) to Dec. 2023 (€0.10 Mil) but then increased from Dec. 2023 (€0.10 Mil) to Jun. 2024 (€0.12 Mil).

Genflow Biosciences's annual common stock increased from Dec. 2021 (€0.09 Mil) to Dec. 2022 (€0.10 Mil) and increased from Dec. 2022 (€0.10 Mil) to Dec. 2023 (€0.10 Mil).


Genflow Biosciences Common Stock Historical Data

The historical data trend for Genflow Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Common Stock Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Common Stock
0.09 0.10 0.10

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial 0.10 0.10 0.10 0.10 0.12

Genflow Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines